$OKLO

DeWitte Jacob sold $3.2M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 60,000 shares of Oklo Inc. (OKLO) at $52.80 ($3.17M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The newest disclosed fact is the CEO/co-founder’s open-market sale of 60,000 shares at $52.80 on July 1 under a 10b5-1 plan, leaving 511,533 shares.

02

Market read

This provides a concrete insider selling datapoint, but it is not a fundamental catalyst given the pre-arranged nature of the trade.

03

What to watch

Traders may over-weight insider sales; without accompanying guidance, financing, or operational updates, the signal is likely weak.

Relevance 5/10Novelty 3/10Timing: filed July 2, covering a July 1 sale

Background

The article is an SEC Form 4 insider transaction report for Oklo Inc., filed July 2, 2026.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder and CEO DeWitte Jacob sold 60,000 shares on July 1 at $52.80 via a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely short-lived unless accompanied by other company-specific news.

Evidence & confidence

Form 4 discloses the sale size and price, but the presence of a pre-arranged 10b5-1 plan reduces the likelihood of it reflecting new negative information.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the transaction may be mechanically scheduled and not predictive of near-term fundamentals.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • DeWitte Jacob

    Co-Founder and CEO, reported the sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.